VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AAPG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AAPGAscentage Pharma Group International
$13.01$1.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAAPGQuarterly Financials

Ascentage Pharma Group International (AAPG) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Ascentage Pharma Group International (AAPG) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

AAPG Income Statement

Quarterly statement

AAPG Income Statement

Ascentage Pharma Group International (AAPG) annual income statement — 10-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q4'25Q2'25Q4'24Q2'24Q4'23Q2'23Q4'22Q2'22Q4'21Q2'21Q4'20Q2'20Q4'19Q2'19Q4'18Q2'18Q4'17Q2'17
Sales/Revenue298.88M334.13M233.7M156.9M823.75M79.28M142.7M104.86M104.86M14.95M12.96M6.22M6.22M7.26M7.26M5.11M1.7M6.05M275.25K
Revenue Growth %27.89%112.95%-71.63%97.9%477.26%-24.39%36.09%601.61%708.76%140.08%108.27%-14.21%-14.21%42.03%327.36%-15.59%516.9%--
Cost of Goods Sold48.01M68.69M21.65M14.03M15.06M12.39M18.15M11M11M739K2.59M983K983K1.05M1.05M-504.49K504.49K-276.84K276.84K
COGS % of Revenue16.06%20.56%9.26%8.94%1.83%15.63%12.72%10.49%10.49%4.94%19.97%15.79%15.79%14.44%14.44%-9.87%29.71%-4.57%100.58%
Gross Profit250.86M265.45M212.05M142.88M808.69M66.89M124.55M93.86M93.86M14.21M10.38M5.24M5.24M6.21M6.21M5.11M-363.27K6.33M-1.6K
Gross Margin %83.94%79.44%90.74%91.06%98.17%84.37%87.28%89.51%89.51%95.06%80.03%84.21%84.21%85.56%85.56%100%-21.39%104.57%-0.58%
Gross Profit Growth %18.3%85.79%-73.78%113.59%549.3%-28.73%32.7%560.68%804.55%171%97.94%-15.57%-15.57%21.52%1809.07%-19.28%-22661.09%--
Operating Expenses994.82M906.3M766.03M709.66M620.7M598.96M465.12M518.76M518.76M447.21M447.21M337.21M337.21M297.55M297.55M215.65M6.84M134.53M2.47M
OpEx % of Revenue332.85%271.24%327.79%452.29%75.35%755.46%325.94%494.74%494.74%2992.36%3449.35%5417.07%5417.07%4100.48%4100.48%4220.88%402.8%2222.55%897.47%
Selling, General & Admin316.01M318.79M237.47M206.5M176.63M201.8M174.66M164.01M164.01M95.63M95.63M32.03M32.03M49.43M49.43M42.53M1.58M12.62M787.26K
SG&A % of Revenue105.73%95.41%101.61%131.61%21.44%254.53%122.4%156.41%156.41%639.88%737.61%514.52%514.52%681.13%681.13%832.53%92.89%208.46%286.02%
Research & Development678.8M587.52M528.56M503.17M444.08M397.16M309.81M371.55M371.55M383.25M383.25M282.29M282.29M231.94M231.94M244.3M5.26M117.13M1.68M
R&D % of Revenue227.12%175.83%226.17%320.68%53.91%500.93%217.11%354.35%354.35%2564.37%2956%4534.71%4534.71%3196.33%3196.33%4781.81%309.9%1935.19%611.45%
Other Operating Expenses0000-2K0-1000K-1000K-1000K-1000K-1000K1000K1000K1000K1000K-1000K01000K0
Operating Income-743.95M-640.85M-553.98M-566.79M187.98M-532.07M-340.57M-424.9M-424.9M-434.92M-434.92M-331.97M-331.97M-291.34M-291.34M-338.24M-7.2M-128.2M-2.47M
Operating Margin %-248.91%-191.8%-237.05%-361.23%22.82%-671.09%-238.66%-405.23%-405.23%-2910.12%-3354.55%-5332.86%-5332.86%-4014.92%-4014.92%-6620.49%-424.19%-2117.98%-898.05%
Operating Income Growth %-34.29%-13.07%-394.7%-6.53%155.2%-25.22%19.85%2.3%2.3%-31.01%-31.01%-13.95%-13.95%13.87%-3944.88%-163.85%-191.39%--
EBITDA-701.08M-598.95M-510.03M-521.96M235.39M-491.3M-303.96M-420.34M-394.48M-432.72M-432.72M-329.98M-329.98M-289.43M-289.43M-319.56M-6.7M-115.97M-2.19M
EBITDA Margin %-234.57%-179.26%-218.24%-332.66%28.58%-619.68%-213.01%-400.88%-376.21%-2895.43%-3337.61%-5300.95%-5300.95%-3988.56%-3988.56%-6254.91%-394.48%-1916.02%-797.47%
EBITDA Growth %-37.46%-14.75%-316.68%-6.24%177.44%-16.88%22.95%2.86%8.84%-31.13%-31.13%-14.01%-14.01%9.43%-4220.96%-175.55%-205.16%--
D&A (Non-Cash Add-back)42.88M41.9M43.95M44.83M47.41M40.76M36.61M4.56M30.43M2.2M2.2M1.99M1.99M1.91M1.91M18.68M504.49K12.22M276.84K
EBIT-743.95M-640.85M-553.98M-566.79M187.98M-532.07M-304.74M-417.19M-417.19M-407.76M-407.76M-334.6M-334.6M-739.02M-739.02M-211.24M314.98K-60.56M-1.62M
Net Interest Income9.07M23.99M3.61M1.43M-28.04M-20.28M-43.37M-21.53M-21.53M-4.81M-4.81M-518.5K-518.5K4.32M4.32M-27.47M-2.39M-55.66M-1.98M
Interest Income35.59M49.78M3.61M1.43M0032.41M4.86M4.86M3.55M3.55M2.61M2.61M6.45M6.45M7.06M0304K0
Interest Expense26.52M25.79M0028.04M20.28M75.78M26.39M26.39M8.37M8.37M3.13M3.13M2.14M2.14M34.53M2.39M55.96M1.98M
Other Income/Expense-50.55M2.14M-31.33M8.64M-25.09M-1.19M-59.04M-18.68M-18.68M18.79M7.31M-5.75M-5.75M-449.82M-449.82M-20.13M011.68M-1.13M
Pretax Income-794.51M-638.72M-585.31M-558.15M162.9M-533.26M-399.6M-443.59M-443.59M-416.12M-374.38M-337.72M-337.72M-741.16M-741.16M-358.37M-2.07M-116.52M-3.6M
Pretax Margin %-265.83%-191.16%-250.46%-355.73%19.77%-672.59%-280.03%-423.05%-423.05%-2784.37%-2887.59%-5425.29%-5425.29%-10213.71%-10213.71%-7014.44%-122.09%-1925.04%-1307.28%
Income Tax13.47M1.4M5.51M10.36M69K-9.9M2.75M-2.12M-2.12M-24.91M-24.91M1.08M1.08M-801K-801K801K-63.06K-1.54M-58.21K
Effective Tax Rate %-1.7%-0.22%-0.94%-1.86%0.04%1.86%-0.69%0.48%0.48%5.99%6.65%-0.32%-0.32%0.11%0.11%-0.22%3.04%1.32%1.62%
Net Income-807.68M-639.96M-590.77M-568.43M163M-523.29M-402.35M-441.46M-441.46M-391.21M-391.21M-338.8M-338.8M-740.36M-740.36M-343.3M-2.01M-114.97M-3.54M
Net Margin %-270.24%-191.53%-252.79%-362.28%19.79%-660.01%-281.96%-421.02%-421.02%-2617.68%-3017.45%-5442.62%-5442.62%-10202.67%-10202.67%-6719.45%-118.38%-1899.53%-1286.13%
Net Income Growth %-36.72%-12.58%-462.43%-8.63%140.51%-18.53%8.86%-12.84%-12.84%-15.47%-15.47%54.24%54.24%-115.66%-36732.23%-198.59%43.22%--
Net Income (Continuing)-807.98M-640.12M-590.82M-568.51M162.83M-523.36M-402.35M-441.46M-441.46M-391.21M-391.21M-338.8M-338.8M-740.36M-740.36M-343.3M-2.01M-114.97M-3.54M
Discontinued Operations0000000000000000000
Minority Interest9.45M9.76M9.91M9.97M10.04M10.21M10.29M000000000000
EPS (Diluted)-8.68-6.92-6.92-7.282.20-7.20-45.28-26.80-26.80-24.56-24.56-25.12-25.12-56.00-56.00-26.52-0.16-8.88-0.29
EPS Growth %-25.43%4.95%-414.55%-1.11%104.86%73.13%-68.96%-9.12%-9.12%2.23%2.23%55.14%55.14%-111.16%-34900%-198.65%44.83%--
EPS (Basic)-8.68-6.92-6.92-7.282.20-7.20-45.28-26.80-26.80-24.56-24.56-25.12-25.12-56.00-56.00-26.52-0.16-8.88-0.29
Diluted Shares Outstanding93.31M92.6M85.4M78.09M74.01M72.51M17.64M16.48M16.48M15.91M15.91M13.49M13.49M13.22M13.22M12.94M12.29M12.94M12.29M
Basic Shares Outstanding93.31M92.6M85.37M78.09M74.01M72.51M17.64M16.48M16.48M15.91M15.91M13.49M13.49M13.22M13.22M12.94M12.29M12.94M12.29M
Dividend Payout Ratio-------------------